PDL BioPharma
In Joel Greenblatt's portfolio · Gotham Asset Management
Ticker PDLI
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Gotham Asset Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q4 2013 | Add 16% | 3,343,973 | 0.7% |
| Q3 2013 | Add 25% | 2,890,564 | 0.7% |
| Q2 2013 | First 13F | 2,315,381 | 0.8% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.